POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1065
https://www.valueinhealthjournal.com/article/S1098-3015(21)02860-6/fulltext
Title :
POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02860-6&doi=10.1016/j.jval.2021.11.1065
First page :
Section Title :
Open access? :
No
Section Order :
10599